Smith & Nephew (SNN) Change in Inventory (2023 - 2024)

Smith & Nephew (SNN) reported Change in Inventory of -$119.0 million for Q4 2024, up 41.67% on a YoY basis from -$84.0 million in Q1 2024, and up 41.67% quarter-over-quarter from -$204.0 million in Q4 2023.

Smith & Nephew (SNN) Change in Inventory (2023 - 2024) Analysis & Trends

Smith & Nephew has reported Change in Inventory for 2 years, with the latest figure at -$119.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 420.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 127.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 171.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -38.50 Mn
10 Smith & Nephew 5.27 Bn 4.69 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -119.00 Mn
Dec 31, 2024 -119.00 Mn
Dec 31, 2023 -204.00 Mn
Dec 31, 2023 -204.00 Mn